Director, Upstream Product Marketing – Early Stage PSMA

See Yourself at Telix

The Director, Product Marketing – Upstream Early-Stage PSMA is a senior strategic leader responsible for shaping the future of Telix’s PSMA imaging portfolio by driving the early-stage commercial strategy for next-generation diagnostic products. This role leads opportunity identification, commercial hypothesis development, and pre-PMC business case creation to ensure that early concepts are clinically meaningful, commercially viable, and aligned with Telix’s long-term franchise strategy. As Director, you will partner closely with Global Development Leads (GDLs), Commercial Strategy & Operations, Medical Affairs, Business Development, and regional commercial teams to define target product profiles (TPPs), influence clinical plans, and guide the strategic direction of Telix’s early PSMA innovation pipeline.

Key Accountabilities:

• Strategic Opportunity Leadership & Early Commercial Strategy
  • Lead regional opportunity and identification for new PSMA imaging concepts aligned with Telix’s long-term franchise and portfolio strategy.
  • Direct comprehensive market assessments to quantify unmet needs, commercial potential, and competitive advantage.
  • Own the development of early commercial strategy, articulating long-range positioning, market differentiation, and value creation pathways.
  • Define and guide Target Product Profiles (TPPs) in collaboration with GDLs and Medical Affairs to ensure development programs are grounded in customer and market needs.
  • Engage regional leaders to gather, analyze, and integrate early customer insights that shape development priorities and early-stage decision-making.
• Business Case Ownership & PMC Influence
  • Lead the creation of high-quality, strategic business cases for early PSMA opportunities, including TAM/SAM models, adoption scenarios, and value assessments.
  • Collaborate with Commercial Strategy & Operations to develop and challenge early financial models, forecasts, and scenario planning.
  • Shape early pricing, access, and reimbursement assumptions to ensure commercial feasibility.
  • Present strategic recommendations to leadership, governing bodies, and PMC pre-review forums to influence go/no-go investment decisions.
  • Ensure early-stage programs are well-prepared for seamless transition into late-stage development.
• Cross-Functional Leadership & Early Development Integration
  • Serve as the senior commercial lead for early-stage PSMA programs, ensuring commercial guidance is deeply integrated into clinical and regulatory strategies.
  • Partner with GDLs, Medical Affairs, and Clinical Development to influence protocol direction and evidence-generation priorities.
  • Lead alignment across regions, ensuring early-stage insights, voice-of-customer (VoC), and market requirements are consistently communicated and embedded in development planning.
  • Provide early strategic guidance to downstream marketing teams to facilitate long-term brand and launch planning
• Market Intelligence, Pipeline Monitoring & Strategic Foresight
  • Provide competitive intelligence and foresight on emerging PSMA technologies, clinical trends, and pipeline dynamics.
  • Identify early opportunities and risks that could influence Telix’s future positioning, lifecycle strategy, or partnership pathways.
  • Develop strategic dashboards and intelligence briefs for senior leadership to support portfolio decisions.
  • Collaborate with Corporate Strategy and BD on partnership evaluations, external innovation scans, and potential licensing opportunities.
• Strategic Program Management & Portfolio Leadership
  • Lead cross-functional strategic initiatives and early-stage commercial workstreams, ensuring disciplined execution and timely delivery.
  • Manage governance routines, executive updates, and decision-making materials for early development and portfolio prioritization.
  • Provide commercial rigor, clear risk-benefit evaluation, and customer-driven rationale to support strategic prioritization across the pipeline.

Education and Experience:

• Bachelor’s degree in Marketing, Business, Life Sciences, or related field; MBA or advanced degree strongly preferred.
• 8–12+ years of relevant experience in pharmaceutical, biotech, diagnostics, business development, or strategic marketing.
• Significant experience in upstream, early product strategy, or franchise-level portfolio planning—preferably in oncology, urology, or molecular imaging.
• Strong analytical capabilities with demonstrated expertise in forecasting, TAM/SAM modeling, and business case development.
• Proven ability to translate complex scientific, clinical, and market insights into actionable commercial strategy.
• Demonstrated leadership and influence across matrixed organizations.
• Exceptional communication skills, with the ability to present recommendations to senior and executive leadership.
• Strong program leadership, prioritization, and decision-making skills in fast-paced environments.
• Travel: 35% - 50%, conservatively.

Success Metrics

•  Delivery of strategic, evidence-based business cases that shape PMC decisions and portfolio direction.
• Strong alignment between early-stage development plans and long-term commercial strategy.
• Clear, data-driven opportunity assessments that strengthen portfolio prioritization.
• Successful progression of early PSMA programs into late-stage development with validated commercial hypotheses.
• Recognition as a trusted, strategic partner to GDLs, Medical, Commercial Strategy, and regional PX teams.